| Issue |
Section |
Title |
File |
| Vol 50, No 1 (2022) |
ARTICLES |
Clinical features of the microRNA genes methylation in borderline ovarian tumors and depending on the histological structure in ovarian malignancies |
(Rus)
|
| Vol 51, No 1 (2023) |
ARTICLES |
Galectin-3 and matrix metalloproteinases 2 and 9 in peripheral blood of gastric cancer patients |
(Rus)
|
| Vol 51, No 3 (2023) |
ARTICLES |
The relationship between urine steroid metabolome and the course of adrenocortical cancer |
(Rus)
|
| Vol 52, No 3 (2024) |
ARTICLES |
The content of soluble forms of galectins -1, -3, -4, -7, -9 in patients with renal cell cancer of various morphological types |
(Rus)
|
| Vol 52, No 3 (2024) |
ARTICLES |
Identification of activating somatic mutations in the PIK3CA gene in breast tumors and determination of their minimal set for clinical diagnostic testing |
(Rus)
|
| Vol 52, No 3 (2024) |
ARTICLES |
Detection of colorectal cancer associated circular RNAs hsa_circ_0031263, hsa_circ_0072715, and hsa_circ_0136666 in plasma with nanowire chips |
(Rus)
|
| Vol 52, No 4 (2024) |
ARTICLES |
Clinical significance of analysis of long non-coding RNA PSMB8-AS1, MBNL1-AS1, and OLMALINC expression by polymerase chain reaction in non-small cell lung cancer |
(Rus)
|
| Vol 53, No 2 (2025) |
ARTICLES |
Immunohistochemical analysis of PD-L1, CD4, CD8, CD20, and PU.1 expression in a dedifferentiated chondrosarcoma: the clinical and prognostic value |
(Rus)
(Eng)
|
| Vol 52, No 6 (2024) |
ARTICLES |
Soluble galectin-4 in colorectal cancer is associated with tumor progression, but is not a predictor of the disease outcome |
(Rus)
|
| Vol 53, No 1 (2025) |
ARTICLES |
Serum levels of the soluble transmembrane adhesion molecule P-cadherin in healthy women and in patients with malignant and benign ovarian tumors |
(Rus)
|
| Vol 53, No 3 (2025) |
ARTICLES |
Increased serum galectin-3 levels is an unfavorable prognostic factor in epithelial ovarian cancer |
(Rus)
|
| Vol 53, No 5 (2025) |
ARTICLES |
Prognostic value of serum galectins-1, -3, -4, -7, -9 in renal cell carcinoma patients |
(Rus)
|
